GSK wins new reprieve as Hikma's generic Advair delayed again

GSK wins new reprieve as Hikma's generic Advair delayed again(Reuters) - GlaxoSmithKline has won a further reprieve for its blockbuster Advair lung drug after U.S. regulators insisted Hikma Pharmaceuticals conduct a further clinical study evaluating its generic version of the drug. The Jordan-based firm said on Monday it expected to submit a response to the U.S. Food and Drug Administration (FDA) with new clinical data in 2019. Hikma's partner on the project, Vectura , said this meant a potential approval and launch of the generic inhaled medication could come in 2020 if all goes well.




from Yahoo News - Latest News & Headlines http://ift.tt/2FMvd6G
via Latest News

Comments

Post a Comment

Popular posts from this blog

5 new Google gadgets that leaked ahead of the company's big October event

Image
5 new Google gadgets that leaked ahead of the company's big October event    Business Insider Animation reveals possible Google Pixel wireless charging stand    The Verge Google app 8.22 details Pixel Stand, Assistant Household, & preps Podcasts auto-downloads [APK Insight]    9to5Google [Exclusive] Google Home Hub To Be Launched On October 9; A Smart Speaker with 7-inch Display    MySmartPrice Gear Full coverage from Technology - Google News https://ift.tt/2I4HOB1 via Technology
Read more